T. B. Chudiwal and I. O. Sharma, “Lixisenatide: a once-daily glucagon-like peptide-1 receptor agonist”, Int J Basic Clin Pharmacol, vol. 5, no. 6, pp. 2311–2320, Dec. 2016.